Saioa Mendaza
Pamplona, NC 31008, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis.
Journal: Biomedicines
Published: July 19, 2021
Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix.
Journal: Cancers
Published: March 09, 2021
Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix.
Journal: International journal of molecular sciences
Published: February 07, 2020
ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer.
Journal: International journal of molecular sciences
Published: January 14, 2020
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer.
Journal: Clinical epigenetics
Published: July 07, 2016
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.
Journal: Oncotarget
Published: July 04, 2016
Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA.
Journal: Virchows Archiv : an international journal of pathology
Published: November 24, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026